Serendex Pharmaceuticals A/S : Minutes of Serendex’s Extraordinary General Meeting 2016	12.07.16
Serendex Pharmaceuticals A/S : Savara Pharmaceuticals acquires Serendex	21.06.16
Serendex Pharmaceuticals A/S : First patient dosed in Serendex’s pivotal trial for PAP	25.05.16
Serendex Pharmaceuticals A/S : signs license agreement with Japanese partner	12.05.16
Serendex Pharmaceuticals A/S : Delisting of Serendex as of 4 May 2016	02.05.16

Unternehmensprofil

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	+17,99 %	125 Mrd.
REGENERON PHARMACEUTICALS, INC.	+13,91 %	108 Mrd.
BIONTECH SE	-6,92 %	23,64 Mrd.
ARGENX SE	+2,47 %	22,39 Mrd.
GENMAB A/S	-12,11 %	17,78 Mrd.
WUXI APPTEC CO., LTD.	-41,64 %	16,43 Mrd.
BEIGENE, LTD.	-15,58 %	16,34 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+0,18 %	13,56 Mrd.
SAREPTA THERAPEUTICS, INC.	+24,44 %	11,59 Mrd.